A former Harvard scientist, who was convicted in the United States for lying to American officials about payments from China, has rebuilt a high-profile brain-computer interface research laboratory in China.
The 67-year-old American scientist was convicted of lying to officials about his ties to the Chinese state program to recruit foreign talent and spent two days in prison and six months under house arrest.
Scientist Charles Lieber, once a leading nanoscience researcher at Harvard University, now leads China’s state-backed i-BRAIN initiative in Shenzhen.
Lieber’s return to active research marks a dramatic change for a figure once considered one of the world’s leading minds in nanoscale science.
In China, he now oversees work on brain-computer interface (BCI) systems technology designed to translate brain activity into digital commands that can control external devices such as robotic systems or computers. Their work reignited the global debate about how far advanced neurotechnology could go in the future of medicine and warfare.
According to the project description, the lab is developing advanced, non-invasive neural interface systems intended to enable communication between the human brain and machines.
The research is part of China’s broader push to become a global leader in next-generation neurotechnology.
China has already elevated brain-computer interfaces to a national strategic priority, with government-backed institutions investing heavily in the field and pushing for rapid commercialization.
Some trials in the country are exploring how BCIs could help paralyzed patients regain movement, while others are examining broader systems of human-machine interaction.
Lieber’s lab operates within the Shenzhen Medical Research and Translation Academy, where it has access to advanced nanofabrication tools and specialized research infrastructure. Chinese officials have positioned the facility as part of a broader effort to attract top global scientific talent to strategic technology sectors.
The development also comes amid growing competition between the United States and China over advanced technologies, including artificial intelligence, quantum systems and neuroengineering. US officials have previously warned that such technologies could have dual-use implications, spanning both civilian healthcare and military modernization.
Lieber has not commented publicly in detail about his new role, but has previously said that his scientific goal is to advance cutting-edge research in brain interfaces and nanotechnology.
